Showing 15,481 - 15,500 results of 100,434 for search '(( 5 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.64s Refine Results
  1. 15481
  2. 15482
  3. 15483

    Table_1_Developmental Fluoxetine Exposure Alters Behavior and Neuropeptide Receptors in the Prairie Vole.DOCX by Rebecca H. Lawrence (9645335)

    Published 2020
    “…FLX exposure decreased oxytocin receptor binding in the nucleus accumbens core and central amygdala, and vasopressin 1a receptor binding in the medial amygdala. …”
  4. 15484

    Image_1_Developmental Fluoxetine Exposure Alters Behavior and Neuropeptide Receptors in the Prairie Vole.TIF by Rebecca H. Lawrence (9645335)

    Published 2020
    “…FLX exposure decreased oxytocin receptor binding in the nucleus accumbens core and central amygdala, and vasopressin 1a receptor binding in the medial amygdala. …”
  5. 15485

    Data_Sheet_2_Sox9 Determines Translational Capacity During Early Chondrogenic Differentiation of ATDC5 Cells by Regulating Expression of Ribosome Biogenesis Factors and Ribosomal P... by Marjolein M. J. Caron (9313694)

    Published 2021
    “…Introduction<p>In addition to the well-known cartilage extracellular matrix-related expression of Sox9, we demonstrated that chondrogenic differentiation of progenitor cells is driven by a sharply defined bi-phasic expression of Sox9: an immediate early and a late (extracellular matrix associated) phase expression. …”
  6. 15486

    Data_Sheet_1_Sox9 Determines Translational Capacity During Early Chondrogenic Differentiation of ATDC5 Cells by Regulating Expression of Ribosome Biogenesis Factors and Ribosomal P... by Marjolein M. J. Caron (9313694)

    Published 2021
    “…Introduction<p>In addition to the well-known cartilage extracellular matrix-related expression of Sox9, we demonstrated that chondrogenic differentiation of progenitor cells is driven by a sharply defined bi-phasic expression of Sox9: an immediate early and a late (extracellular matrix associated) phase expression. …”
  7. 15487
  8. 15488
  9. 15489
  10. 15490
  11. 15491

    Healthcare use, sickness absence, and disability pension among colorectal cancer survivors and population references in Sweden by Luisa Christine Beermann (11422044)

    Published 2021
    “…</p> <p>In this longitudinal register-based cohort study, 6679 patients with a first primary CRC in 2008–2011 (when aged 18–62) and 26,716 CRC-free matched references were followed from 2 years before up to 5 years after diagnosis date. …”
  12. 15492
  13. 15493
  14. 15494
  15. 15495

    datasheet1_PRMT5 Prevents Cardiomyocyte Hypertrophy via Symmetric Dimethylating HoxA9 and Repressing HoxA9 Expression.docx by Sidong Cai (9435359)

    Published 2020
    “…In cardiomyocyte hypertrophy induced by β-adrenergic receptor agonist isoprenaline (ISO), PRMT5 expression was decreased while HoxA9 was upregulated. …”
  16. 15496
  17. 15497

    Beta-catenin signaling in the E14.5 cortex. by Christopher A. Mutch (243132)

    Published 2010
    “…<p>(<b>A</b>) This series of images represent rostral, middle, and caudal coronal sections (from left to right) of an E14.5 Axin2-d2EGFP forebrain hemisphere, stained with anti-GFP antibody (green) and DAPI (blue). …”
  18. 15498
  19. 15499

    SUMOylation leads to synergistic activation of a cardiac-specific promoter by Nkx2-5. by Mauro W. Costa (205822)

    Published 2011
    “…(C) HEK293T were transiently transfected with wildtype Nkx2-5 or with a homeodomain point mutant that decreases DNA binding affinity. …”
  20. 15500